Source: THE UNIVERSITY OF TEXAS AT AUSTIN submitted to
ENGINEERING BACTERIA TO COMBAT BEE PATHOGENS
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
1030005
Grant No.
2023-67012-39356
Cumulative Award Amt.
$225,000.00
Proposal No.
2022-09624
Multistate No.
(N/A)
Project Start Date
Mar 1, 2023
Project End Date
Feb 28, 2025
Grant Year
2023
Program Code
[A1113]- Pollinator Health: Research and Application
Project Director
Lariviere, P. J.
Recipient Organization
THE UNIVERSITY OF TEXAS AT AUSTIN
101 EAST 27TH STREET STE 4308
AUSTIN,TX 78712-1500
Performing Department
(N/A)
Non Technical Summary
The honey bee is one of the most ecologically and economically important pollinators worldwide. Perhaps the biggest threat facing bees (both in industry and nature) is pathogen-borne disease. Two of the most prominent bee diseases, American foulbrood and Varroa mite infection, have been difficult to contain, contributing to over $300 million in hive replacement costs per year and declining food security. Current therapeutics lack specificity, efficacy, and tolerable side-effect profiles. Fortunately, synthetic biology offers a solution through the use of symbiont engineering. Bee symbionts have previously been genetically modified to combat Varroa infections in individual adult bees. However, larval and hive-level infections remain untamed. Further, use of symbionts to combat foulbrood has not yet been attempted. In this proposal, I aim to engineer hive-associated bacteria to kill bee pathogens. The natural hive-associated bacterium Bombella apis will be engineered to express antimicrobial bacteriocins to target the foulbrood-causing agent Paenibacillus larvae. Additionally, B. apis will be used to kill larvae-associated Varroa mites through symbiont-mediated RNAi. Efficacy for both therapeutics will be measured in terms of effective pathogen killing and improvement of bee larval survival and health.This research project aims to provide novel therapeutics in the fight against two of the biggest bee pathogens, leading to improved efficiency of natural and commercial crop pollination. This work directly addresses NIFA AFRI Farm Bill Priority Area PHPPP, Program Area 1f. Pollinator Health: Research and Application (A1113) through the development of new therapeutics to promote pollinator health. Finally, note that research using engineered organisms will becarried out in a laboratory (not outdoors), according tostandard biosafety procedure.
Animal Health Component
100%
Research Effort Categories
Basic
(N/A)
Applied
100%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31130101100100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3010 - Honey bees;

Field Of Science
1100 - Bacteriology;
Goals / Objectives
Goal: Engineer bee larval symbiotic bacteria tocombat larval bee disease.Objective 1: Engineer the bee larval symbiont Bombella apisto be able to inhibit the growth of the causitive agent of American Foulbrood,Paenibacillus larvae, in a larval disease model. This objective will be achieved by engineering B. apisto secreteP.larvae-specific antimicrobial bacteriocins that have been identified through a bioinformatic pipeline.Objective 2:Engineer Bombella apisto kill bee larvae-associatedVarroa mites in a larval disease model. This objective will be achieved by engineering B. apisto secreteVarroa-specific dsRNA, using dsRNA constructs previously shown to killVarroamites in adult bees.
Project Methods
The objectives (1. EngineerB. apisto killP. larvae; 2. EngineerB. apisto kill bee larval-associatedVarroamites) will each be divided into 4 four phases:Phase 1: Plasmid/strain engineeringDesign and construct plasmids to expressP. larvae-targeting bacteriocins, export machinery, and immunity protein (Obj. 1)Conjugate bacteriocin- and dsRNA-expressing plasmids intoB. apiswith a conjugation competentE. colistrain (Obj. 1&2)Phase 2:in vitrotestingTest bacteriocin/dsRNA expression by B. apis(Obj. 1&2)Test bacteriocin/dsRNA secretion byB. apis(Obj. 1&2)Test bacteriocin activity againstP. larvaein vitro (Obj. 1)Test dsRNA activity against Varroamitesin vitro(Obj. 2)Phase 3: Test effectors efficacyin infection models (in 96 well plates)Quantify pathogen killing when exposed to treatment16s rRNA qPCR (Obj. 1)Mite mortality quantification (Obj. 2)Monitor pathogen activity (Obj. 1)Holst milk testMonitor health of treated bee larvae infected withP. larvae (Obj. 1)Quantify bee larval survivalMonitor marker of bee larval health (def-1 levels)Check for bee larval dysbiosisMonitor health of treated bee larvae infected with Varroamites (Obj. 2)Quantify bee larval survivalMonitor marker of bee larval health (relishlevels)Quantify the presence of DWV in adult bees (by qPCR)Score adult bees for deformed wingsPhase 4: Performin situeffector testing (in hive frames)Quantify pathogen killing when exposed to treatment16s rRNA qPCR (Obj. 1)Mite mortality quantification (Obj. 2)Monitor health of treated bee larvae infected withP. larvae(Obj. 1)Quantify bee larval survivalMonitor marker of bee larval health (def-1 levels)Check for bee larval dysbiosisMonitor health of treated bee larvae infected withVarroamites (Obj. 2)Quantify bee larval survivalMonitor marker of bee larval health (relishlevels)Quantify the presence of DWV in adult bees (by qPCR)Score adult bees for deformed wingsDistinctionsfrom previous work:Utilization of larval symbiont to deliver effectorsExpression of pathogen-specific bacteriocins to kill a bacterial pathogen (P. larvae)Targeting of larval-specific Varroamites using symbiont-delivered (B. apis) dsRNAVarroamites have previously been targeted with symbiont delivered dsRNA in adultbees, using an adult-specific symbiont (S. alvi)The use of a larval-specific symbiont, to target larval-specific Varroamite infections is novelMeans of communication:Publication of research in scientific journalsPresentation of research via poster/oral presentations at conferencesTimeline:Four months will be allocated for the completion of each Objective's phase (8 phases, across 2 Objectives = 2 years).Evaluation of this research's impact on the target audience will be conducted quarterly according to the following criteria:Alignment with the timeline scheduleAchievement of key research goals according to the timelineKey challenges faced and overcomeQuantity and impact of relevant manuscriptsFeedback will be solicited (and used to update the research plan) at the following venues:Quarterly meetings with mentors and collaboratorsYearly meeting with advisory committeeConsisting of internal (mentors/collaborators) and external stakeholders

Progress 03/01/23 to 02/29/24

Outputs
Target Audience:Target audience: Beekeepers: Beekeepers were targeted because they face annual colony loss due to pathogenic infection and parasitic infestation of hives, resulting in economic loss. There is an unmet need for tools to combat these diseases in a safe manner. Beekeepers were targeted short term and long term. Short term, through seminar disseminating work. Long term, through research to provide tools to improve bee health. Undergraduates: Undergraduates were targeted to provide hands on training in research and biology, one of the goals of the University, and to promote interest in pollinator research. I provided mentorship to one undergraduate who contributed to this project, over the course of the 2023-2024 school year. Scientists in the fields of microbiology, host-symbiont interactions, and pollination: Microbiologists were targeted because the genome engineering tools we are developing for engineering bee gut bacteria have broader applicability and have the potential to inform genome engineering tool development in other bacteria. Host-symbiont scientists were targeted because the genome engineering tools we are developing will enable new lines of investigation into host-symbiont interactions, through the easy use of reverse genetics. Pollinator (eg, honey bee) scientists were targetedbecause our research will enable easiser study of honey bee microbes and hopes to provide tools for improving bee health. Scientists were targeted short term and long term. Short term, through seminars, poster sessions, and publication of reserach. Long term, trhough research to provide tools to engineer and study bee gut symbionts, and to improve bee health. Changes/Problems:B. apis isolation and engineering proof of concept: This project uses the bacteriaB. apis, but the strain we had in lab was mislabeled. Prior to my joining the lab, a former trainee had misnamed (and published on)a bacterial strain as B. apis.Before starting my experiments, I performed 16S rDNA sequencing, and discovered this was a different bacterial species. I therefore had to isolate B. apis from our bee hives and verify that it was the correct species. Following this, I needed to perform proof of concept work to demonstrate feasbility of engineeringB. apis. The ability to engineer "B. apis"had previously been shown and was a foundation for the research project, but once we realized this strain was misnamed, we realized we needed to demonstrate that we could engineer the real B. apis. I successfully conjugated a plasmid, demonstrating that this species is in fact capable of being engineered. From this proof of concept study, we identified key plasmid parameters (origin of replication, antibiotic resistance cassette, promoter) that facilitate successful engineering. Demonstration of feasibility of engineering B. apismeans that we will now be able to work towardsengineering it according to the aims of the project. We have also added focus to additional aspects of engineering bee gut symbionts and understanding their interaction with the honey bee host, including developing a method for easy genome engineering of bee symbionts (preprint deposited), characterizing colonization of a bee symbiont (manuscript submission targeted for June 2024), and characterizing interaction of a symbiont with the bee via extracellular vesicles. What opportunities for training and professional development has the project provided?Mentorship recieved by PJ Lariviere: While working on this project, I have received mentorship from my advisor (Moran) and co-advisor (Barrick). I meet with Dr. Moran one-on-one every two weeks, where I have a chance to recieve training in experimental design and data interpretation. I have recieved similar advice from Dr. Barrick in less formal settings. I present my research at both lab meetings every few months and recieve higher level feedback from both advisors, as well as labmates. I have also received mentorship from both advisors during the manuscript writing process, as both advisors contribute substantially to manuscript editing and helping shape the overall story. Additional training recieved by PJ Lariviere: I received formal beekeeping training from an expert in the lab. Through multiple training sessions, I have been trained on how to work with bee hives, including handling bee frames, assessing overall health of the hive, cleaning the hive, and maintaining the status of a single queen per hive. Mentorship/training received by undergraduate: I am currently mentoring one undergraduate (10 hrs/week) who is performing wet lab reserach on this project. I have trained her in multiple research techniques, including rearing honey bee larvae in lab, performing PCR, performing bacterial cell culture, and bacterial genome engineering. She has also received formal training to work with bee hives. Professional development: I have participated in multiple conferences that increased my knowledge of host-symbiont interactions and bacterial genome engineering. Conferences include ASM Microbe 2023, NSF EDGE meeting 2023, and the NSFBuild-a-Cell Workshop 2023. I also received training in curriculum development through participation in a series of Instructor Learning Community meetings, where instructors met mutliple times a semester to discuss the merits of content reduction in curriculum, using data to inform our perspectives. Finally, as the project lead on this research project, I have gained experimence managing a researchbudget. How have the results been disseminated to communities of interest?Research into development of tools to engineering the bacteria of bee guts and applications aimed at imrpoving bee health have been disseminated through seminars and conferences. I spoke at the Northern Colorado Beekeepers Association, to communicate directly to beekeepers the research that is being done to engineer the honey bee microbiome to combat disease. I gave a poster presentation at ASM Microbe 2023 to communicate a protocol we developed to engineer the genome of bacterialhoney beesymbiontsto other microbiologists. I also gave a poster presentation at NSF EDGE 2023 on work describing use of engineered honey bee symbionts to combat bee disease, with the target audience being other biologists that are developing genome engineering tools. In April 2024, I gave a deparmental seminar describing how a bacterial symbiont colonizes the honey bee, with the target audience being researchers in the molecular biosciences. Work describing use of engineered bee gut symbionts to combat Nosema infection was published in a journal article, with the target audience being other researchers and stakeholders interested in improving bee health. Work describing a protocol for engineering the genome of bacterial bee gut symbionts has been deposited to a preprint server and is currently under review at mBio. What do you plan to do during the next reporting period to accomplish the goals?We have made headway towards engineering B. apis and demonstrating colonization of larvae in our lab, but have not yet demonstrated pathogen killing. Within the next reporting period, efforts will aim to: 1. EstablishP. larvae, and eventually, Varroa,killing assays -We have had initial challenges purifying P. larvae spores, possibly due to attempting purification at too small of a scale. We will plan to scale up purification and will reach out to Dr. Jay Evans (USDA Bee Research lab), our collaborator who supplied the strains of P. larvae, for advice 2. EngineerB. apisto express effectors against Varroa and P. larvae -We do not anticipate major challenges here, as we demonstrated B. apis can be engineered 3. Test ability of WT B. apis to prevent P. larvae infection -Once we have the P. larvae infection assay up and running, we will be able to test this immediately 4. Test ability of engineered B. apis to kill P. larvae in vitro and in vivo -We may face challenges for the in vivo tests if our engineered B. apis has difficulty killing P. larvae in vitro. If this is the case, we will troubleshoot in vitro killing and test additional antimicrobial peptides for P. larvae killing.

Impacts
What was accomplished under these goals? Honey bees are critical pollinators in agriculture. Honey bees face annual colony loss due to pathogens/parasites, causing economic loss. Bee susceptibility to disease has revealed a need for tools to combat disease, as well as investigation into how bees interact with microbes, with an aim to improve bee health. Work here has focused on development of genome engineering tools for bee symbionts, and engineering bee symbionts to combat disease and investigate how certain symbionts interact with the bee. In the near term, other honey bee researchers will profit from our contributions to the field, both in terms of increased understanding of how symbionts interact with honey bees, but also specifically through use of a simple method for engineering the genome of honey bee symbionts that we developed. Other microbiologists and host-symbiont scientists will also benefit, as the genome engineering method we developed has the potential to be used in other bacteria. Longer term, commercial beekeepers and farmers stand to benefit from our research into honey bee therapeutics, as these aim to combat the pathogens driving colony loss. Any insight gained into the development of solutions for combating bee disease has the potential to decrease colony loss, thereby improving efficiency of the pollinator industry and more broadly, food security. Goals and accomplishments: Goal: Isolate the bee symbiont B. apis -We determined we had the wrong species of symbiont isolated, so we re-isolated this symbiont from our bee hives and verified that it is the correct one. Goal: Engineering the bee symbiont B. apis -We performed a proof of concept study to demonstrate the feasibility of engineering this symbiont -We were able to successfully engineer this symbiont (by transfer of plasmid by conjugation) and showed that it could express fluorescent protein in lab -We were able to determine key parameters required for successful engineering (origin of replication, promoter, antibiotic resistance cassette) Goal: Establish larval rearing assay in lab -We successfully established the ability to rear bee larvae in our lab in 48-well plate format, a key feature necessary for performing tests on therapeutic efficacy Goal: Establish B. apis colonization protocol of larvae -We successfully established the ability to colonize larvae in our lab with the symbiont B. apis, another key feature necessary for being able to deliver therapeutics to the larvae Goals: Establish P. larvae killing assay and engineer B. apis to express effectors -We have initiated work to establish a P. larvae killing assay and to engineer B. apis to express effectors. These are in progress. Goal: Develop genome engineering protocol for bee bacterial symbionts -We have developed a simple method for engineering the genome of bacterial bee symbionts. -We describe this method in a manuscript that has been deposited to a preprint server and the manuscript is currently under review at mBio. Goal: Characterize colonization of bee by a bacterial symbiont -We have characterized the colonization of the bee by a bacterial symbiont -We find that biofilm formation is required for colonization by the symbiont S. alvi -We utilized the genome engineering protocol we developed (above) to drive this investigation -We aim to submit a manuscript describing these findings in June 2024. Goal: Characterize interaction of a bacterial symbiont with the bee -We are using reverse genetics assess how a bacterial symbiont uses vesicles to interact with the bee -We are using the genome engineering protocol we developed (above) to engineer strains to help with this goal Summary of key outcomes/accomplishments: 1. Isolated B. apis and demonstrated feasibility of engineering this symbiont 2. Established ability in our lab to rear bee larvae and colonize with B. apis 3. Initiated work to establish P. larvae killing assay and engineer B. apis to express effectors 4. Wrote manuscript describing method for engineering the genomes of diverse bee symbionts (under review) 5. Finished collecting data for 2nd manuscript, describing colonization of bee by a bacterialsymbiont (submission target: June 2024)submitted 6. Presented posters/oral presentations describing key findings from both manuscripts above 7. Initiated work to characterize the interaction of a bacterial symbiont through vesicles

Publications

  • Type: Journal Articles Status: Under Review Year Published: 2023 Citation: Lariviere, P. J. et al. Single-step genome engineering in the bee gut symbiont Snodgrassella alvi. BioRxiv Prepr. Serv. Biol. 2023.09.19.558440 (2023) doi:10.1101/2023.09.19.558440. Under review at mBio.
  • Type: Journal Articles Status: Published Year Published: 2023 Citation: Huang, Q., Lariviere, P. J., Powell, J. E. & Moran, N. A. Engineered gut symbiont inhibits microsporidian parasite and improves honey bee survival. Proc. Natl. Acad. Sci. 120, e2220922120 (2023).